Determinants of resistance to engineered T cell therapies targeting CD19 in large B cell lymphomas
大B细胞淋巴瘤中针对CD19的工程化T细胞疗法产生耐药性的决定因素
期刊:Cancer Cell
影响因子:48.8
doi:10.1016/j.ccell.2022.12.005
Brian J Sworder,David M Kurtz,Stefan K Alig,Matthew J Frank,Navika Shukla,Andrea Garofalo,Charles W Macaulay,Mohammad Shahrokh Esfahani,Mari N Olsen,James Hamilton,Hitomi Hosoya,Mark Hamilton,Jay Y Spiegel,John H Baird,Takeshi Sugio,Mia Carleton,Alexander F M Craig,Sheren F Younes,Bita Sahaf,Natasha D Sheybani,Joseph G Schroers-Martin,Chih Long Liu,Jean S Oak,Michael C Jin,Sara Beygi,Andreas Hüttmann,Christine Hanoun,Ulrich Dührsen,Jason R Westin,Michael S Khodadoust,Yasodha Natkunam,Robbie G Majzner,Crystal L Mackall,Maximilian Diehn,David B Miklos,Ash A Alizadeh